Preserved Na+/H+ exchanger isoform 3 expression and localization, but decreased NHE3 function indicate regulatory sodium transport defect in ulcerative colitis

Inflammatory Bowel Diseases

Volumn 16, Issue 7, 2010, Pages 1149-1161

  Yeruva, Sunil ^a   Farkas, Klaudia ^b   Hubricht, Jessica ^a   Rode, Katja ^a   Riederer, Brigitte ^a   Bachmann, Oliver ^a   Cinar, Ayhan ^a   Rakonczay, Zoltán ^b   Molnár, Tamás ^b   Nagy, Ferenc ^b   Wedemeyer, Jochen ^a   Manns, Michael ^a   Raddatz, Dirk ^c   Musch, Mark W ^d   Chang, Eugene B ^d   Hegyi, Péter ^b   Seidler, Ursula ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Electrolyte transport; Inflammatory bowel disease; Inflammatory diarrhea; Intestinal inflammation; Na+ H+ exchange; Sodium absorption

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MESALAZINE; METHOTREXATE; SODIUM PROTON EXCHANGE PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; VILLIN;

ARTICLE; BRUSH BORDER; CLINICAL ARTICLE; COLON BIOPSY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE CRYPT; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGMOID; SODIUM ABSORPTION; SODIUM TRANSPORT; ULCERATIVE COLITIS;

BLOTTING, WESTERN; COLITIS, ULCERATIVE; COLON; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL ABSORPTION; ION TRANSPORT; MICROVILLI; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM; SODIUM-HYDROGEN ANTIPORTER; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953699752     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21183     Document Type: Article

References (52)

1. Sandle GI. Pathogenesis of diarrhea in ulcerative colitis: new views on an old problem. J Clin Gastroenterol. 2005;39:S49-S52.
2. Seidler U, Lenzen H, Cinar A et al. Molecular mechanisms of disturbed electrolyte transport in intestinal inflammation. Ann N Y Acad Sci. 2006;1072:262-275.
3. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129:550-564.
4. Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol. 2007;23:379-383.
5. Weber CR, Nalle SC, Tretiakova M, et al. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88:1110-1120.
6. Amasheh S, Barmeyer C, Koch CS, et al. Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology. 2004;126:1711-1720.
7. Yang HY, Jiang W, Furth EE, et al. Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. Am J Physiol Gastrointest Liver Physiol. 1998;38:G1445-G1453.
8. Greig ER, Boot-Handford RP, Mani V, et al. Decreased expression of apical Na+ channels and basolateral Na+, K+-ATPase in ulcerative colitis. J Pathol. 2004;204:84-92.
9. Rachmilewitz D, Karmeli F, Sharon P. Decreased colonic Na-K-ATPase activity in active ulcerative colitis. Isr J Med Sci. 1984;20:681-684. (Pubitemid 14035879)
10. Caprilli R, Frieri G, Latella G, et al. Faecal excretion of bicarbonate in ulcerative colitis. Digestion. 1986;35:136-142. (Pubitemid 16001673)
11. Lohi H, Makela S, Pulkkinen K, et al. Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2002;283:G567-G575.
12. Sullivan S, Alex P, Dassopoulos T, et al. Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea. Inflamm Bowel Dis. 2009;15:261-274.
13. + exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 50aminosalicylate treatment. Scand J Gastroenterol. 2009;44:56-64
14. Rocha F, Musch MW, Lishanskiy L, et al. IFN-gamma downregulates expression of Na(+)/H(+) exchangers NHE2 and NHE3 in rat intestine and human Caco-2/bbe cells. Am J Physiol Cell Physiol. 2001;280:C1224-C1232.
15. Sugi K, Musch MW, Field M, et al. Inhibition of Na+,K+-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function. Gastroenterology. 2001;120:1393-1403. (Pubitemid 32322313)
16. Amin MR, Dudeja PK, Ramaswamy K, et al. Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-gamma/TNF-alpha. Am J Physiol Gastrointest Liver Physiol. 2007;293:G374-G382.
17. Clayburgh DR, Musch MW, Leitges M, et al. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest. 2006;116:2682-2694.
18. Cinar A, Chen M, Riederer B, et al. NHE3 inhibition by cAMP and Ca2+ is abolished in PDZ-domain protein PDZK1-deficient murine enterocytes. J Physiol. 2007;581(Pt 3):1235-1246.
19. von Herbay A. [Histopathologic diagnosis of chronic inflammatory intestinal diseases. Historical review and current survey.] Pathologe. 1999;20:276-287.
20. Broere N, Chen M, Cinar A, et al. Defective jejunal and colonic salt absorption and altered Na(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice. Pflugers Arch. 2009;457:1079-1091.
21. Seidler U, Rottinghaus I, Hillesheim J, et al. Sodium and chloride absorptive defects in the small intestine in Slc26a6 null mice. Pflugers Arch. 2008;455:757-766.
22. Stockmann M, Gitter AH, Sorgenfrei D, et al. Low edge damage container insert that adjusts intestinal forceps biopsies into Ussing chamber systems. Pflugers Arch. 1999;438:107-112.
23. Zhao H, Shiue, H, Palkon S, et al. Ezrin regulates NHE3 translocation and activation after Na+-glucose cotransport. Proc Natl Acad Sci U S A. 2004;101:9485-9490.
24. Hegyi P, Rakonczay Z Jr, Gray MA, et al. Measurement of intracellular pH in pancreatic duct cells: a new method for calibrating the fluorescence data. Pancreas. 2004;28:427-434.
25. Raddatz D, Bockemuhl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol. 2005;17:547-557.
26. Sawa Y, Oshitani N, Adachi K, et al. Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease. Int J Mol Med. 2003;11:175-179.
27. Arai F, Takahashi T, Furukawa K, et al. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease. Dig Dis Sci. 1998;43:2071-2079. (Pubitemid 128689192)
28. Dionne S, Hiscott J, D'Agata I, et al. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci. 1997;42:1557-1566.
29. Will PC, Cortright RN, Groseclose RG, et al. Amiloride-sensitive salt and fluid absorption in small intestine of sodium-depleted rats. Am J Physiol Gastrointest Liver Physiol. 1985;248(1 Pt 1):G133-G141.
30. Will PC, Cortright RN, DeLisle RC, et al. Regulation of amiloridesensitive electrogenic sodium transport in the rat colon by steroid hormones. Am J Physiol Gastrointest Liver Physiol. 1985;248(1 Pt 1):G124-G132.
31. Yu FH, Shull GE, Orlowski J. Functional properties of the rat Na/H exchanger NHE-2 isoform expressed in Na/H exchanger-deficient Chinese hamster ovary cells. J Biol Chem. 1993;268:25536-25541.
32. Musch MW, Clarke LL, Mamah D, et al. T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. J Clin Invest. 2002;110:1739-1747.
33. Archampong EQ, Harris J, Clark CG. The absorption and secretion of water and electrolytes across the healthy and the diseased human colonic mucosa measured in vitro. Gut. 1972;13:880-886.
34. Hawker PC, McKay JS, Turnberg LA. Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease. Gastroenterology. 1980;79:508-511.
35. Gitter AH, Wullstein F, Fromm M, et al. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology. 2001;121:1320-1328. (Pubitemid 33140449)
36. Sandle GI, Higgs N, Crowe P, et al. Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology. 1990;99:97-105. (Pubitemid 20202496)
37. Allgayer H, Kruis W, Paumgartner G, et al. Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Dig Dis Sci. 1988;33:417-422.
38. Todd RA., Grinstein S. Tethering, recycling, and activation of the epithelial sodium proton exchanger, NHE3. J Exp Biol. 2009;212:1630-1637.
39. Cuthbert AW, Halstead J, Ratcliff R, et al. The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol. 1995;482(Pt 2):449-454.
40. Bachmann O, Riederer B, Rossmann H, et al. The Na+/H+ exchanger isoform 2 is the predominant NHE isoform in murine colonic crypts and its lack causes NHE3 upregulation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G125-133 (Pubitemid 38802126)
41. Crowe SE, Luthra GK, Perdue MH. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut. 1997;41:785-792.
42. Suzuki A, Hanada T, Mitsuyama K, et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med. 2001;193:471-481.
43. Horino J, Fujimoto M, Terabe F, et al. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. Int Immunol. 2008;20:753-762.
44. Zachos NC, Tse M, Donowitz M. Molecular physiology of intestinal Na+/H+ exchange. Annu Rev Physiol. 2005;67:411-443.
45. Shkoda A, Werner T, Daniel H, et al. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J Proteome Res. 2007;6:1114-1125.
46. Wu F, Dassopoulos T, Cope L, et al. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis. 2007;13:807-821.
47. Aronson PS. Kinetic properties of the plasma membrane Na+-H+ exchanger. Annu Rev Physiol. 1985;47:545-560.
48. Wakabayashi S, Hisamitsu T, Pang T, et al. Kinetic dissection of two distinct proton binding sites in Na+/H+ exchangers by measurement of reverse mode reaction. J Biol Chem. 2003;278:43580-43585.
49. Wakabayashi S, Fafournoux P, Sardet C, et al. The Na+/H+ antiporter cytoplasmic domain mediates growth factor signals and controls "H(+)-sensing." Proc Natl Acad Sci U S A. 1992;89:2424-2428.
50. Li S, Sato S, Yang X, et al. Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3. J Clin Invest. 2004;114:1782-1789.
51. Tsuganezawa H, Sato S, Yamaji Y, et al. Role of c-SRC and ERK in acid-induced activation of NHE3. Kidney Int. 2002;62:41-50.
52. Yang X, Huang HC, Yin H, et al. RhoA required for acid-induced stress fiber formation and trafficking and activation of NHE3. Am J Physiol Renal Physiol. 2007;293:F1054-F1064. (Pubitemid 47583937)